ClinicalTrials.gg
RecruitingNCT07426549Updated Jul 20, 2026

Close Chain and Open Chain Exercises With Blood Flow Restriction in Knee Osteoarthritis

An interventional study of Closed kinetic chain exercises with blood flow restriction and Open kinetic chain exercises with blood flow restriction in Knee Osteoarthristis, sponsored by Riphah International University. Recruiting at 2 sites in Pakistan. Open to participants aged 45 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
45 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 74 studies in Osteoarthritis, Knee by Riphah International University — 21 open to participants now, 22 under way, none of them phase 3. Osteoarthritis, Knee · Riphah International University.

Planned enrollment
35th of 71
40 · median 40
Started
2026
with 9 others
No phase
71 of 74
21 open now
Primary completion
2026-10
later than 18 of 21 live
Registered
65th of 74
by date

Among the 74 studies in Osteoarthritis, Knee by Riphah International University, this one is the 35th largest by planned enrollment of the 71 interventional ones that give a count, is one of 10 that started in 2026, is one of 71 with no phase, reaches primary completion later than 18 of the 21 other live ones, and was the 65th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

21 of the 74 studies in Osteoarthritis, Knee by Riphah International University are open now, in 1 country. Recruiting first, the newest first:

15 more — sign in →

By country, each count listing its studies:

All 21 open studies →

Where they have run

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 45 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 74 studies in Osteoarthritis, Knee by Riphah International University, or all of them as a file.
02

Study summary

The aim of this research is to find and compare the effect of close chain and open chain exercises with blood flow restriction in knee osteoarthritis on pain, range of motion, strength and functional performance in patients with knee osteoarthritis. Randomized controlled trials done at Railway General Hospital and Medistic Medical and Dental Center, Rawalpindi. The sample size was 40. The subjects were divided in two groups, 20 subjects in close chain exercises with blood flow restriction group and 20 in open chain exercises with blood flow restriction group. Study duration was of 4 weeks. Sampling technique applied was purposive non probability sampling technique. Only 45-75 years individual with grade 1 or 2 knee osteoarthritis were included. Tools used in the study are Numeric pain rating scale (NPRS), Western Ontario and McMaster Universities Arthritis Index (WOMAC), goniometer, crane scale (dynamometer), 30 s chair stand test. Data was analyzed through SPSS 21.

03

Conditions studied

  • Knee Osteoarthristis

Keywords

  • Knee Osteoarthritis
  • Blood Flow Restriction
  • Blood Flow Resriction Therapy
  • Knee Joint
04

Who can participate

Ages eligible
45 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Radiologic confirmation of KOA demonstrating Kellgren-Lawrence grade 1 or 2.
  • Exhibited symptoms of unilateral KOA.
  • Not taking any medications for KOA or receiving other treatments (including physiotherapy).
  • Willing to participate without any neurological symptoms were the main objects of study.

Exclusion criteria

Exclusion Criteria:

  • A history of knee surgery or scheduled surgery.
  • Kellgren-Lawrence grade 3 or 4.
  • Systolic blood pressure over 160 mm Hg or under 100 mm Hg.
  • Use of nonsteroidal anti-inflammatory drugs in the past 3 months.
  • Any known vascular disease or any diagnosed blood pathology.
  • Concomitant symptomatic hip or ankle pathology that could influence knee pain or function.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Closed kinetic chain exercises with blood flow restriction

    Closed kinetic chain exercises with blood flow restriction and conservative therapy

    Other: Closed kinetic chain exercises with blood flow restriction

  • Active comparator
    Open kinetic chain exercises with blood flow restriction

    Open kinetic chain exercises with blood flow restriction and conservative therapy.

    Other: Open kinetic chain exercises with blood flow restriction

Interventions

  • OtherClosed kinetic chain exercises with blood flow restriction

    Closed kinetic chain exercises with blood flow restriction and conservative therapy. Participants in this group will receive conventional physiotherapy including hot pack application over the knee for 10 minutes and TENS applied medial and lateral to the knee for 10 minutes prior to exercises. Mulligan mobilization with movement will be performed using pain free sustained tibial glides during active knee flexion and extension. Closed kinetic chain quadriceps strengthening exercises will include seated heel press, mini squats, wall slides, step ups, and step downs performed under blood flow restriction. Exercises will be performed using a standardized blood flow restriction protocol of 4 sets with repetitions of 30, 15, 15, and 15 at low load. Sessions will be conducted 3 days per week for 4 weeks, with a total of 12 sessions, each session lasting approximately 40 minutes.

  • OtherOpen kinetic chain exercises with blood flow restriction

    Open kinetic chain exercises with blood flow restriction and conservative therapy. Participants in this group will receive conventional physiotherapy including hot pack application over the knee for 10 minutes and TENS applied medial and lateral to the knee for 10 minutes prior to exercises. Mulligan mobilization with movement will be performed using pain free sustained tibial glides during active knee flexion and extension. Open kinetic chain quadriceps strengthening exercises will include straight leg raises and knee extension exercises performed under blood flow restriction. Exercises will be performed using a standardized blood flow restriction protocol of 4 sets with repetitions of 30, 15, 15, and 15 at low load. Sessions will be conducted 3 days per week for 4 weeks, with a total of 12 sessions, each session lasting approximately 40 minutes

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale (NPRS)

    Changes from baseline pain intensity will be assessed using the Numeric Pain Rating Scale. The Numeric Pain Rating Scale is a subjective pain assessment tool ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Participants will be asked to rate their average knee pain intensity at rest and during activity. NPRS is widely used in clinical practice due to its simplicity, reliability, and responsiveness to change in musculoskeletal conditions.

    Time frame: [Time Frame: Pre intervention (Week 1) and Post intervention (Week 4)]

Secondary outcomes

  1. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    Changes from baseline pain, stiffness, and physical function will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index, a validated questionnaire for individuals with knee osteoarthritis.

    Time frame: [Time Frame: Pre intervention (Week 1) and Post intervention (Week 4)]

  2. Knee Range of Motion (Flexion)

    Changes from baseline knee flexion range of motion will be measured using a universal goniometer following standard procedures.

    Time frame: [Time Frame: Pre intervention (Week 1) and Post intervention (Week 4)]

  3. Knee Range of Motion (Extension)

    Changes from baseline knee extension range of motion will be measured using a universal goniometer in a standardized position.

    Time frame: [Time Frame: Pre intervention (Week 1) and Post intervention (Week 4)]

  4. Knee Muscle Strength

    Changes from baseline knee extensor muscle strength will be assessed using a crane scale (dynamometer) in a standardized testing position.

    Time frame: [Time Frame: Pre intervention (Week 1) and Post intervention (Week 4)]

  5. 30 Second Chair Stand Test

    Changes from baseline functional lower limb strength will be assessed using the 30 second chair stand test, which measures the number of sit to stand repetitions completed in 30 seconds.

    Time frame: [Time Frame: Pre intervention (Week 1) and Post intervention (Week 4)]

07

Study locations

1 of 2 sites recruiting
  • Medistic Medical and Dental Center
    Rawalpindi, Pakistan
    Recruiting
  • Pakistan Railway General Hospital
    Rawalpindi, Pakistan
    Not yet recruiting
    • Muhammad Affan Iqbal, PhD* · Contactaffan.iqbal@riphah.edu.pk · 03336754837
    • Neha Maqsood, DPT · Principal investigator
    • Muhammad Affan Iqbal, PhD* · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Oct 2026, 4 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 4 months is below that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 17, 2026
First posted
Feb 23, 2026
StartActual
Jun 30, 2026
Primary completionEst.
Oct 30, 2026
CompletionEst.
Nov 7, 2026
Last update
Jul 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07426549
Responsible party
Sponsor
First posted
Feb 23, 2026
Start date
Jun 30, 2026
Primary completion
Oct 30, 2026 (estimated)
Completion
Nov 7, 2026 (estimated)
Last update
Jul 20, 2026

Study contacts

Imran Amjad, PhD
Contact
imran.amjad@riphah.edu.pk
03324390125
Muhammad Affan Iqbal, PhD*
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion